1133 related articles for article (PubMed ID: 16601194)
1. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.
Habashi JP; Judge DP; Holm TM; Cohn RD; Loeys BL; Cooper TK; Myers L; Klein EC; Liu G; Calvi C; Podowski M; Neptune ER; Halushka MK; Bedja D; Gabrielson K; Rifkin DB; Carta L; Ramirez F; Huso DL; Dietz HC
Science; 2006 Apr; 312(5770):117-21. PubMed ID: 16601194
[TBL] [Abstract][Full Text] [Related]
2. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.
Gambarin FI; Favalli V; Serio A; Regazzi M; Pasotti M; Klersy C; Dore R; Mannarino S; Viganò M; Odero A; Amato S; Tavazzi L; Arbustini E
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):354-62. PubMed ID: 19430350
[TBL] [Abstract][Full Text] [Related]
4. Medicine. Old drug, new hope for Marfan syndrome.
Travis J
Science; 2006 Apr; 312(5770):36-7. PubMed ID: 16601163
[No Abstract] [Full Text] [Related]
5. miR-29b participates in early aneurysm development in Marfan syndrome.
Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):305-312.e2. PubMed ID: 20189193
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states.
Cohn RD; van Erp C; Habashi JP; Soleimani AA; Klein EC; Lisi MT; Gamradt M; ap Rhys CM; Holm TM; Loeys BL; Ramirez F; Judge DP; Ward CW; Dietz HC
Nat Med; 2007 Feb; 13(2):204-10. PubMed ID: 17237794
[TBL] [Abstract][Full Text] [Related]
8. AT1 receptor antagonism to reduce aortic expansion in Marfan syndrome: lost in translation or in need of different interpretation?
Mallat Z; Daugherty A
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):e10-2. PubMed ID: 25550201
[No Abstract] [Full Text] [Related]
9. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?
Matt P; Habashi J; Carrel T; Cameron DE; Van Eyk JE; Dietz HC
J Thorac Cardiovasc Surg; 2008 Feb; 135(2):389-94. PubMed ID: 18242274
[TBL] [Abstract][Full Text] [Related]
10. Investigation of Strategies to Block Downstream Effectors of AT1R-Mediated Signalling to Prevent Aneurysm Formation in Marfan Syndrome.
Valdivia Callejon I; Buccioli L; Bastianen J; Schippers J; Verstraeten A; Luyckx I; Peeters S; Danser AHJ; Van Kimmenade RRJ; Meester J; Loeys B
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732244
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.
Habashi JP; Doyle JJ; Holm TM; Aziz H; Schoenhoff F; Bedja D; Chen Y; Modiri AN; Judge DP; Dietz HC
Science; 2011 Apr; 332(6027):361-5. PubMed ID: 21493863
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and Management of Cardiovascular Manifestations in Marfan and Loeys-Dietz Syndromes.
Takeda N; Yagi H; Hara H; Fujiwara T; Fujita D; Nawata K; Inuzuka R; Taniguchi Y; Harada M; Toko H; Akazawa H; Komuro I
Int Heart J; 2016 May; 57(3):271-7. PubMed ID: 27181042
[TBL] [Abstract][Full Text] [Related]
13. The Effect of a Nonpeptide Angiotensin II Type 2 Receptor Agonist, Compound 21, on Aortic Aneurysm Growth in a Mouse Model of Marfan Syndrome.
Verbrugghe P; Verhoeven J; Clijsters M; Vervoort D; Schepens J; Meuris B; Herijgers P
J Cardiovasc Pharmacol; 2018 Apr; 71(4):215-222. PubMed ID: 29300219
[TBL] [Abstract][Full Text] [Related]
14. Update on Clinical Trials of Losartan With and Without β-Blockers to Block Aneurysm Growth in Patients With Marfan Syndrome: A Review.
Hofmann Bowman MA; Eagle KA; Milewicz DM
JAMA Cardiol; 2019 Jul; 4(7):702-707. PubMed ID: 31066871
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.
Nistala H; Lee-Arteaga S; Carta L; Cook JR; Smaldone S; Siciliano G; Rifkin AN; Dietz HC; Rifkin DB; Ramirez F
Hum Mol Genet; 2010 Dec; 19(24):4790-8. PubMed ID: 20871099
[TBL] [Abstract][Full Text] [Related]
16. Paternal fibrillin-1 mutation transmitted to an affected son with neonatal marfan syndrome: the importance of early recognition.
Elshershari H; Harris C
Cardiol Young; 2014 Aug; 24(4):735-8. PubMed ID: 23930893
[TBL] [Abstract][Full Text] [Related]
17. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
[TBL] [Abstract][Full Text] [Related]
18. Therapy insight: aortic aneurysm and dissection in Marfan's syndrome.
Ramirez F; Dietz HC
Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):31-6. PubMed ID: 16265257
[TBL] [Abstract][Full Text] [Related]
19. Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial.
Radonic T; de Witte P; Baars MJ; Zwinderman AH; Mulder BJ; Groenink M;
Trials; 2010 Jan; 11():3. PubMed ID: 20067609
[TBL] [Abstract][Full Text] [Related]
20. Targeting TGF-beta and the extracellular matrix in Marfan's syndrome.
Kalluri R; Han Y
Dev Cell; 2008 Jul; 15(1):1-2. PubMed ID: 18606132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
